EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--April 20, 2006--Savient Pharmaceuticals Inc. (NASDAQ: SVNT - News), an emerging specialty pharmaceuticals company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, today announced that Christopher Clement, President and Chief Executive Officer, will present at the UBS Global Specialty Pharmaceuticals Conference on Monday, April 24, 2006 at 12:30 p.m. EDT at the Grand Hyatt in New York City.
